Clinical Trials Logo

Primary Plasma Cell Leukemia clinical trials

View clinical trials related to Primary Plasma Cell Leukemia.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06333509 Not yet recruiting - Multiple Myeloma Clinical Trials

Anti-GPRC5D CAR-T Cells (CT071) in Participants With RRMM or RRpPCL

Start date: April 15, 2024
Phase: Phase 1/Phase 2
Study type: Interventional

A Phase 1/2 Open label, multicenter, clinical trial of autologous CAR T-cell therapy targeting GPRC5D, in participants with relapsed/refractory multiple myeloma or relapsed/refractory primary plasma cell leukemia.